{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:49:50Z","timestamp":1788871790244,"version":"build-2803163510"},"reference-count":17,"publisher":"Elsevier BV","issue":"37","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,6]],"date-time":"2014-08-06T00:00:00Z","timestamp":1407283200000},"content-version":"vor","delay-in-days":370,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado da Bahia\u2013FAPESB [Conv\u00eanio 160\/03]"},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","award":["476860\/2007-5"],"award-info":[{"award-number":["476860\/2007-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior (CAPES)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.vaccine.2013.04.079","type":"journal-article","created":{"date-parts":[[2013,5,15]],"date-time":"2013-05-15T15:34:12Z","timestamp":1368632052000},"page":"3778-3782","source":"Crossref","is-referenced-by-count":9,"title":["Interferon-gamma production by mononuclear cells in Bacille Calmette-Gu\u00e9rin-revaccinated healthy volunteers predicted long-term antimycobacterial responses in a randomized controlled trial"],"prefix":"10.1016","volume":"31","author":[{"given":"Evelin S.","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamocyr M.","family":"Marinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theolis","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2013.04.079_bib0005","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S1472-9792(12)70005-7","article-title":"Tuberculosis vaccines: a strategic blueprint for the next decade","volume":"92","author":"Brennan","year":"2012","journal-title":"Tuberculosis"},{"key":"10.1016\/j.vaccine.2013.04.079_bib0010","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2249.2012.04614.x","article-title":"Is interferon-gamma the right marker for bacille Calmette-Gu\u00e9rin-induced immune protection? The missing link in our understanding of tuberculosis immunology","volume":"169","author":"Abebe","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2013.04.079_bib0015","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/bmj.2.6082.293","article-title":"BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life","volume":"2","author":"Hart","year":"1977","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2013.04.079_bib0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tube.2007.10.001","article-title":"Comparison of IFN-gamma responses to mycobacterial antigens as markers of response to BCG vaccination","volume":"88","author":"Weir","year":"2008","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.vaccine.2013.04.079_bib0025","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(02)08353-8","article-title":"BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies","volume":"359","author":"Black","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.04.079_bib0030","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2172-11-35","article-title":"Mycobacterium tuberculosis PPD-induced immune biomarkers measurable in vitro following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining","volume":"11","author":"Smith","year":"2010","journal-title":"BMC Immunol"},{"key":"10.1016\/j.vaccine.2013.04.079_bib0035","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1128\/IAI.00004-07","article-title":"Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-Cell epitope mapping and role of gamma interferon","volume":"75","author":"Rado\u0161evi\u0107","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.04.079_bib0040","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1016\/j.vaccine.2011.05.023","article-title":"Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: second report of the BCG-REVAC cluster-randomised trial","volume":"29","author":"Barreto","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.04.079_bib0045","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/S0264-410X(02)00721-1","article-title":"BCG (Bacille of Calmette\u2013Gu\u00e9rin) revaccination leads to improved in vitro IFN-gamma response to mycobacterial antigen independent of tuberculin sensitization in Brazilian school-age children","volume":"21","author":"Barbosa","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.04.079_bib0050","doi-asserted-by":"crossref","first-page":"e000079","DOI":"10.1136\/bmjopen-2011-000079","article-title":"Non-compliance with health surveillance is a matter of biosafety: a survey of latent tuberculosis infection in a highly endemic setting","volume":"1","author":"da Rocha","year":"2011","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2013.04.079_bib0055","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.tube.2012.02.007","article-title":"Mycobacterium tuberculosis-induced neutrophil ectosomes decrease macrophage activation","volume":"92","author":"Duarte","year":"2012","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.vaccine.2013.04.079_bib0060","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1365-2249.2006.03171.x","volume":"146","author":"Peruhype-Magalh\u00e3es","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2013.04.079_bib0065","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1164\/rccm.201003-0334OC","article-title":"Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Gu\u00e9rin vaccination of newborns","volume":"182","author":"Kagina","year":"2010","journal-title":"Am J of Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2013.04.079_bib0070","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1378\/chest.11-3157","article-title":"Predictive value of interferon-\u03b3 release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis","volume":"142","author":"Diel","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.vaccine.2013.04.079_bib0075","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2013.04.079_bib0080","unstructured":"Associa\u00e7\u00e3o Brasileira de Empresas de Pesquisa, Crit\u00e9rio de Classifica\u00e7\u00e3o Econ\u00f4mica Brasil, Portal ABEP (2008)."},{"key":"10.1016\/j.vaccine.2013.04.079_bib0085","series-title":"Physical status: the use and interpretation of anthropometry","author":"World Health Organization","year":"1995"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13005525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13005525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T20:54:33Z","timestamp":1539636873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13005525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":17,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0264410X13005525"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.04.079","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}